Targets/Mutation

Drug

NTRK Fusion

Entrectenib

Larotrectinib

BRAF V600E

Dabrafenib plus trametinib

EGFR exon 20 insertion

Osimertinib

Poziotinib

Mobocertinib (TAK-788)

Compound 1A

Hsp90 (EGFR exon 20 insertion)

Luminespib

EGFR and MET

JNJ-6372

METexon14

Crizotinib

Glesatinib

Tepotinib

Capmatinib

Telisotuzumab vedotin

KRAS G12C

AMG 510

MRTX849

RET

Cabozantinib

Vandetanib

LOXO-292 (Selpercatinib)

Pralsetinib

HER2

Trastuzumab and Trastuzumab emtansine (T-DM1)

Trastuzumab Deruxtecan (DS-8201a)

Dacomitinib

Afatinib

Pyrotinib

FGFR

AZD4547